• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL Back to Search Results
Catalog Number UNKNOWN
Device Problem Off-Label Use (1494)
Patient Problem Obstruction/Occlusion (2422)
Event Type  malfunction  
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Chen et al 2021, management of 6fr polymer ureteric stent failure in the setting of malignant ureteric obstruction.347 patients had jj stent inserted for malignant ureteric obstruction and had at least one stent exchange between 2010 and 2020 (including planned and unplanned).48 patients (63 ureters) experienced stent failure with 6fr polymer ureteric stent and was managed with stent exchange.Group a was managed by an exchange to a new 6 fr polymer stent.9 patients (9 ureters).Group b was managed by an exchange to 8fr polymer stents 30 patients (41 ureters).Group c was managed by an exchange to 6fr resonance® metallic stent 9 patients (13 ureters).This file will capture the stent failure requiring a nephrostomy tube and off label use of twin stenting with the resonance® metallic stent.2 patients had twin 6fr stents inserted after single 6fr polymer stents failure.The other patient had ongoing obstruction with twin 6fr stents and had nephrostomy tube inserted 48 hours later.347 patients had jj stent inserted for malignant ureteric obstruction and had at least one stent exchange between 2010 and 2020 (including planned and unplanned).
 
Manufacturer Narrative
Device evaluation: the resonance stent set device of unknown lot number involved in this complaint was not available for evaluation.With the information provided, a document-based investigation was conducted.This complaint was raised in the literature article chen et al 2021 ¿management of 6fr polymer ureteric stent failure in the setting of malignant ureteric obstruction¿.This study aims to identify the best second-line stent option when 6fr polymer stent fails, before committing to nephrostomy.Stent failure was defined by unplanned stent exchange due to clinical, radiological or biochemical evidence of stent obstructions.The study investigates 347 patients divided into three groups.Group a, group b and group c.Group a was managed by an exchange to a new 6 fr polymer stent 9 patients (9 ureters).Group b was managed by an exchange to 8fr polymer stents30 patients (41 ureters).Group c was managed by an exchange to 6fr resonance® metallic stent 9 patients (13 ureters).48 patients (63 ureters) experienced stent failure with 6fr polymer ureteric stent and was managed with stent exchange.2 patents was fitted with twin 6fr stents after single 6fr polymer stent failure.This file captures the off label use of twin stent insertion of rms devices.Lab evaluation: n/a.Document review: as the rpn and lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution all resonance stent set devices are subject to visual a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.Image review: n/a.Impression: n/a.Root cause review: a definitive root cause of off label use was identified from the available information.The physician opted for twin stenting of rms devices.Off label used complaints are considered to be unforeseen misuse.Summary: the complaint is confirmed based on customer testimony.According to the initial reporter, 2 patients had twin 6fr stents inserted after single 6fr polymer stents failure.The other patient had ongoing obstruction with twin 6fr stents and had nephrostomy tube inserted 48 hours later.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONANCE STENT SET
Type of Device
FAD STENT, URETERAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
aisling hassett
o halloran road
national technology park
limerick 
MDR Report Key13252619
MDR Text Key294137476
Report Number3001845648-2022-00014
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K063742
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location Hospital
Initial Date Manufacturer Received 12/20/2021
Initial Date FDA Received01/13/2022
Supplement Dates Manufacturer Received12/20/2021
Supplement Dates FDA Received04/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-